Results 51 to 60 of about 163,432 (256)
A cross-sectional study of the prevalence, barriers, and facilitators of cervical cancer screening in family planning clinics in Mombasa County, Kenya
BMC Health Services Research, 2022 Background Cervical cancer is the most common cancer in sub-Saharan Africa. With appropriate screening and treatment, cervical cancer can be prevented.McKenna C. Eastment, George Wanje, Barbra A. Richardson, Emily Mwaringa, Shem Patta, Kenneth Sherr, Ruanne V. Barnabas, Kishorchandra Mandaliya, Walter Jaoko, R. Scott McClelland +9 moredoaj +1 more sourceMITF maintains genome stability in nonmelanocyte lineages
Molecular Oncology, EarlyView.MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson +13 morewiley +1 more sourceImpact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study
Infectious Agents and CancerBackground In cervical screening, human papillomavirus (HPV)-positive women at 1-year retesting are typically referred to colposcopy. This study, by the use of extended genotyping, estimates the impact of distinguishing persistent from new infections in ...Annarosa Del Mistro, Pamela Mancuso, Francesca Carozzi, Laura De Marco, Simonetta Bisanzi, Giampaolo Pompeo, Guglielmo Ronco, Silvia Gori, Elena Allia, Daniela Gustinucci, Helena Frayle, Anna Iossa, Elena Cesarini, Simonetta Bulletti, Basilio Passamonti, Jessica Viti, Laura Toniolo, Francesco Venturelli, Paolo Giorgi Rossi, Maria Benevolo, the NTCC2 Working Group +20 moredoaj +1 more sourceCervical Cancer Screening [PDF]
Journal of the National Comprehensive Cancer Network, 2010 These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort.Edward E, Partridge, Nadeem R, Abu-Rustum, Susan M, Campos, Patrick J, Fahey, Michael, Farmer, Rochelle L, Garcia, Anna, Giuliano, Howard W, Jones, Subodh M, Lele, Richard W, Lieberman, Stewart L, Massad, Mark A, Morgan, R Kevin, Reynolds, Helen E, Rhodes, Diljeet K, Singh, Karen, Smith-McCune, Nelson, Teng, Cornelia Liu, Trimble, Fidel, Valea, Sharon, Wilczynski +19 moreopenaire +2 more sourcesCancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies
Molecular Oncology, EarlyView.The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer +7 morewiley +1 more sourceIdentifying transcription factors controlling the basal expression of human MRP4 highlights a substantial role for Sp1
FEBS Open Bio, EarlyView.The MRP4 transporter exports several drugs and signaling molecules. Here, we identified key promoter elements regulating basal MRP4 expression. Using reporter assays, we defined a conserved region with essential Sp1 and contributory Ets sites, which controlled basal MRP4 expression.Debora Singer, Angelique Kragl, Katrin Ziems, Juliane Glaubitz, Sophie Grammbauer, Susanne Hildebrandt, Mladen V. Tzvetkov, Gabriele Jedlitschky +7 morewiley +1 more sourceScalable long-read nanopore HPV16 amplicon-based whole-genome sequencing
Scientific ReportsHuman papillomavirus 16 (HPV16) drives precursor cervical lesions that often progress to cervical cancer (CC). Variation within the HPV16 genome has been associated with CC risk.Maina K. Titus, David Giesbrecht, Cliff I. Oduor, Kapten Muthoka, Karamoko Niaré, Rebecca Crudale, Abebe A. Fola, Sin Ting Hui, Isaac E. Kim, Philip K. Tonui, Peter M. Itsura, Ronald Tonui, Ann M. Moormann, Patrick J. Loehrer, Darron R. Brown, Omenge E. Orang’o, Susan Cu-Uvin, Aaron C. Ermel, Rachel A. Katzenellenbogen, Jeffrey A. Bailey +19 moredoaj +1 more sourcePharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling
FEBS Open Bio, EarlyView.Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...Ada Lerma‐Clavero, Maria Kopsida, Nathalie Arendt, Hans Lennernäs, Markus Sjöblom, Femke Heindryckx +5 morewiley +1 more sourceThe C‐terminal region of KIF26B is indispensable for nephron progenitor condensation and kidney formation in mice
FEBS Open Bio, EarlyView.KIF26B plays an important role in kidney development. We engineered mice lacking the C‐terminal region of KIF26B and found severe kidney defects, including bilateral renal agenesis, similar to full Kif26b knockout mice. The mutation disrupted nephron progenitor condensation and reduced Gdnf‐Wnt11 signaling, showing that the KIF26B C‐terminal region is ...Yuta Yamamura, Kengo Furuichi, Hiromitsu Akamatsu, Naoki Yamamoto, Sako Keisuke, Akihiko Koshino, Taichiro Minami, Megumi Oshima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Kenta Takahashi, Minako Yamamura, Shin‐ichi Horike, Takiko Daikoku, Kenichi Harada, Yohei Shinmyo, Hiroshi Kawasaki, Takashi Wada, Yasunori Iwata +19 morewiley +1 more sourceExtended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study
Microbiology SpectrumThe use of clinically validated human papillomavirus (HPV) assays is recommended in cervical cancer screening, and extended genotyping is getting attention as a triage biomarker because of the different oncogenic risk of the high-risk HPV genotypes.Laura De Marco, Simonetta Bisanzi, Guglielmo Ronco, Pamela Mancuso, Francesca Carozzi, Elena Allia, Raffaella Rizzolo, Daniela Gustinucci, Helena Frayle, Jessica Viti, Anna Iossa, Elena Cesarini, Simonetta Bulletti, Basilio Passamonti, Silvia Gori, Laura Toniolo, Francesco Venturelli, Annarosa Del Mistro, Paolo Giorgi Rossi, Maria Benevolo +19 moredoaj +1 more source